Gapping up
In reaction to strong earnings/guidance: SURG +7.1%, EXPR +7%, CVTI +6.8%, SUPN +5.7%, PME +5.3%, (thinly traded), SYX +5%, FCEL +4.7%, NVTA +3.5%, TCRD +3.1%, EOX +2.8%, SCON +2.7%, GCA +1.9%, TXMD +1.8%, (thinly traded), TSM +1.7%, (reported Feb revs yday) STV +1.6%, PAY +0.9%, NCS +0.9%, SINA +0.6%, T +0.5%, (reiterates 2015 outlook; Provides Q1 update on metric trends ), LOGI +0.5% (reaffirmed FY15), VPG +0.5%, BLT +0.5%
Select Bio/pharma related names showing strength: SUPN +5.7%, GERN +3.4%, CYTX +3%, BIOC +2.4%, ONVO +2.3%, SNY +1.4%, ACAD +0.9%
Other news: MELA +54.8% ( disclosed tha on March 9, 2015, the February 2015 CPT Editorial Summary of Panel Actions was posted to the website of the American Medical Association), BLRX +6.3% (announces positive pre-clinical results for BL-9020 for the treatment of Type 1 diabetes), ARCP +5.1% (announced that the Board has named Glenn J. Rufrano CEO effective April 1, 2015; announced plans to reconstitute the Board of Directors), PTX +5% (Zogenix confirms agreement of sale of Zohydro ER Business to Pernix for $100 million at closing plus potential milestones of $283.5 million), NATH +4.7% (announced a special cash dividend of $25 per share), LL +4% (cont strength from yday), AKRX +4% (provides update on recent product launches), MMI+2.7% ( announces public offering of 4.0 million shares of common stock by selling stockholders; co will not receive any proceeds from the sale of the stock ), GNC +2.6% (GNC Holdings issues statement in response to New York Attorney General; says testing showed that the GNC Herbal Plus products meet all requirements for safety, quality, purity and proper labeling ), TSEM +2.1% (still checking), SUNE +1.9% (CEO bought 32k shares of stock on the open market), NOR +1.7% (announced rate design agreement with the Missouri Public Service Commission), HOV +1.7% (still checking, but did host annual meeting yday and report earnings tomorrow), MBLY +1.5% (Mobileye and Valeo (VLEEY) sign a unique technology cooperation agreement), KYTH +1.3% (prices 2,604,168 shares of its common stock at $48.00 per share), HCC +0.9% (announced new strategic alliance with Weather Analytics, a provider of precision climate and weather data and analytics), SWKS +0.9% (favorable commentary on Tuesday's Mad Money), XONE +0.9% (has appointed Hans J. Sack to serve as President)
Analyst comments: SNDK +3.2% (target raised to $106 from $100 at Goldman -- Added to Conviction Buy List), RRGB +1.5% (upgraded to Buy from Neutral at Longbow), CMG +0.8% (initiated with a Outperform at Credit Suisse)
In reaction to strong earnings/guidance: SURG +7.1%, EXPR +7%, CVTI +6.8%, SUPN +5.7%, PME +5.3%, (thinly traded), SYX +5%, FCEL +4.7%, NVTA +3.5%, TCRD +3.1%, EOX +2.8%, SCON +2.7%, GCA +1.9%, TXMD +1.8%, (thinly traded), TSM +1.7%, (reported Feb revs yday) STV +1.6%, PAY +0.9%, NCS +0.9%, SINA +0.6%, T +0.5%, (reiterates 2015 outlook; Provides Q1 update on metric trends ), LOGI +0.5% (reaffirmed FY15), VPG +0.5%, BLT +0.5%
Select Bio/pharma related names showing strength: SUPN +5.7%, GERN +3.4%, CYTX +3%, BIOC +2.4%, ONVO +2.3%, SNY +1.4%, ACAD +0.9%
Other news: MELA +54.8% ( disclosed tha on March 9, 2015, the February 2015 CPT Editorial Summary of Panel Actions was posted to the website of the American Medical Association), BLRX +6.3% (announces positive pre-clinical results for BL-9020 for the treatment of Type 1 diabetes), ARCP +5.1% (announced that the Board has named Glenn J. Rufrano CEO effective April 1, 2015; announced plans to reconstitute the Board of Directors), PTX +5% (Zogenix confirms agreement of sale of Zohydro ER Business to Pernix for $100 million at closing plus potential milestones of $283.5 million), NATH +4.7% (announced a special cash dividend of $25 per share), LL +4% (cont strength from yday), AKRX +4% (provides update on recent product launches), MMI+2.7% ( announces public offering of 4.0 million shares of common stock by selling stockholders; co will not receive any proceeds from the sale of the stock ), GNC +2.6% (GNC Holdings issues statement in response to New York Attorney General; says testing showed that the GNC Herbal Plus products meet all requirements for safety, quality, purity and proper labeling ), TSEM +2.1% (still checking), SUNE +1.9% (CEO bought 32k shares of stock on the open market), NOR +1.7% (announced rate design agreement with the Missouri Public Service Commission), HOV +1.7% (still checking, but did host annual meeting yday and report earnings tomorrow), MBLY +1.5% (Mobileye and Valeo (VLEEY) sign a unique technology cooperation agreement), KYTH +1.3% (prices 2,604,168 shares of its common stock at $48.00 per share), HCC +0.9% (announced new strategic alliance with Weather Analytics, a provider of precision climate and weather data and analytics), SWKS +0.9% (favorable commentary on Tuesday's Mad Money), XONE +0.9% (has appointed Hans J. Sack to serve as President)
Analyst comments: SNDK +3.2% (target raised to $106 from $100 at Goldman -- Added to Conviction Buy List), RRGB +1.5% (upgraded to Buy from Neutral at Longbow), CMG +0.8% (initiated with a Outperform at Credit Suisse)